Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$637M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$506M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$438M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$277M |
| 5 |
Comcast
CMCSA
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPN
Calpine Corporation
CPN
|
+$298M |
| 2 |
Gilead Sciences
GILD
|
+$235M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$188M |
| 4 |
Apple
AAPL
|
+$180M |
| 5 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.89% |
| 2 | Energy | 4.68% |
| 3 | Technology | 4.17% |
| 4 | Communication Services | 3.74% |
| 5 | Financials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AbbVie
ABBV
$434B
| $99.2M | 0.1% |
1,771,568
-547,588
| -24% | -$28.7M |
|
152
PUT
Biogen
BIIB
$29.7B
| $98.6M | 0.1% |
312,900
-132,800
| -30% | -$40M |
|
153
Equity Residential
EQR
$25.2B
| $98.1M | 0.1% |
1,556,742
-598,603
| -28% | -$36.4M |
|
154
CALL
Chevron
CVX
$384B
| $97.7M | 0.1% |
751,600
+559,900
| +292% | +$69.7M |
|
155
The Mosaic Company
MOS
$6.91B
| $97.6M | 0.1% |
1,992,561
-1,615,971
| -45% | -$79.6M |
|
156
Applied Materials
AMAT
$408B
| $97.5M | 0.1% |
4,430,584
+1,724,629
| +64% | +$35.2M |
|
157
CALL
AstraZeneca
AZN
$244B
| $96.6M | 0.1% |
1,305,600
+1,249,700
| +2,236% | +$90.3M |
|
158
CALL
JPMorgan Chase
JPM
$935B
| $96.2M | 0.1% |
1,688,500
-905,800
| -35% | -$50.9M |
|
|
JNPR
159
DELISTED
Juniper Networks
JNPR
| $95.9M | 0.1% |
3,995,385
+2,256,971
| +130% | +$56.1M |
|
160
CALL
iShares Biotechnology ETF
IBB
$9.17B
| $95.5M | 0.1% |
1,114,200
-529,800
| -32% | -$41.7M |
|
161
CALL
Coca-Cola
KO
$374B
| $95.2M | 0.1% |
2,267,200
+193,300
| +9% | +$7.84M |
|
|
WBA
162
DELISTED
Walgreens Boots Alliance
WBA
| $93.2M | 0.1% |
1,259,932
-121,849
| -9% | -$8.51M |
|
163
PUT
Booking.com
BKNG
$149B
| $92.5M | 0.1% |
1,922,500
-850,000
| -31% | -$40.8M |
|
164
CALL
Altria Group
MO
$114B
| $92.2M | 0.1% |
2,249,600
+1,145,300
| +104% | +$46.1M |
|
165
Welltower
WELL
$168B
| $91.8M | 0.1% |
1,480,460
-395,606
| -21% | -$24.9M |
|
166
CALL
Tesla
TSLA
$1.27T
| $91.6M | 0.1% |
5,724,000
-16,500
| -0.3% | -$230K |
|
167
Energy Transfer Partners
ET
$69.8B
| $91.5M | 0.1% |
3,154,470
+2,171,018
| +221% | +$54.9M |
|
168
Amgen
AMGN
$204B
| $89.5M | 0.09% |
758,649
+12,771
| +2% | +$1.48M |
|
169
Williams Companies
WMB
$86B
| $88.1M | 0.09% |
1,519,321
+164,582
| +12% | +$7.63M |
|
|
QCOR
170
DELISTED
QUESTCOR PHARMA INC
QCOR
| $87.3M | 0.09% |
949,286
+919,934
| +3,134% | +$78.8M |
|
171
CALL
Baidu
BIDU
$38.4B
| $87.3M | 0.09% |
469,300
+46,600
| +11% | +$7.63M |
|
172
Healthpeak Properties
DOC
$14.9B
| $85.8M | 0.09% |
2,298,510
-882,102
| -28% | -$33.2M |
|
173
iShares Core S&P 500 ETF
IVV
$884B
| $85.5M | 0.09% |
434,096
-31,260
| -7% | -$5.98M |
|
174
CALL
IBM
IBM
$215B
| $85.3M | 0.09% |
492,980
+103,136
| +26% | +$18.6M |
|
175
iShares China Large-Cap ETF
FXI
$4.35B
| $85.2M | 0.09% |
2,301,583
-2,190,933
| -49% | -$79.4M |
|
Similar funds
Barclays's Q2 2014 Portfolio in Review
As of Q2 2014, Barclays held 8,150 positions worth $94.6B, up 7.1% from $88.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q2 2014 filing shows 480 new, 3,032 increased, 3,756 reduced and 467 closed positions. Its largest new stake was Blackstone Mortgage Trust: 1,000,000 shares worth $29M. The largest sale was Calpine Corporation, an estimated $298M.
By sector, the portfolio is most concentrated in Healthcare at 4.9% of assets, down from 5.8% a quarter earlier, followed by Energy and Technology.
- Barclays's largest Q2 2014 buy was Blackstone Mortgage Trust: 1,000,000 shares worth $29M.
- Barclays added most to Phillips 66 in Q2 2014, an estimated $637M increase.
- Barclays's biggest Q2 2014 reduction was Calpine Corporation, cutting an estimated $298M.
- Barclays fully exited BRE PROPERTIES INC CL A in Q2 2014, selling an estimated $91.7M.
- Barclays's ten largest holdings make up 26% of its $94.6B portfolio in Q2 2014.
- Barclays opened 480 new positions and closed 467 in Q2 2014.
- Barclays's portfolio value rose 7.1% quarter-over-quarter to $94.6B.
Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.